Photodiagnosis and Photodynamic Therapy
Volume 4, Issue 1 , Pages 3-11 , March 2007

The history of PDT in Norway: Part one: Identification of basic mechanisms of general PDT

  • Asta Juzeniene, PhD, MSc

      Affiliations

    • Department of Radiation Biology, The Norwegian Radium Hospital, Montebello, N-0310 Oslo, Norway
    • Corresponding Author InformationCorresponding author. Tel.: +47 22935113; fax: +47 22934270.
    • ,
  • Johan Moan

      Affiliations

    • Department of Radiation Biology, The Norwegian Radium Hospital, Montebello, N-0310 Oslo, Norway
    • Institute of Physics, Oslo University, Blindern, 0316 Oslo, Norway

References 

  1. Moan J, Sommer S. Fluorescence and absorption properties of the components of hematoporphyrin derivative. Photobiochem Photobiophys. 1981;3:93–103
  2. Moan J, McGhie J, Christensen T. Hematoporphyrin derivative: photosensitzing efficiency and cellular uptake of its components. Photobiochem Photobiophys. 1982;4:337–345
  3. Moan J, Christensen T, Sommer S. The main photosensitizing components of hematoporphyrin derivative. Cancer Lett. 1982;15:161–166
  4. Christensen T, Moan J, McGhie JB, Waksvik H, Stigum H. Studies of HPD: chemical composition and in vitro photosensitization. Adv Exp Med Biol. 1983;160:151–164
  5. Moan J, Sandberg S, Christensen T, Elander S. Hematoporphyrin derivative: chemical composition, photochemical and photosensitizing properties. Adv Exp Med Biol. 1983;160:165–179
  6. Sommer S, Moan J, Christensen T, Evensen JF. A chromatographic study of hematoporphyrin derivatives. In:  Andreoni A,  Cubeddu R editor. Porphyrins in tumor phototherapy. Plenum Publishing Corporation; 1984;p. 81–92
  7. Rimington C, Sommer S, Moan J. Hematoporphyrin ethers. I. Generalized synthesis and chemical properties. Int J Biochem. 1987;19:315–320
  8. Rimington C, Ronnestad A, Western A, Moan J. Hematoporphyrin ethers. II. Improvements in method, synthesis of the dihexyl, dicyclohexanyl and diphenyl ethers and their preliminary biological evaluation. Int J Biochem. 1988;20:1139–1149
  9. Rimington C, Ronnestad A, Evensen JF, Moan J. Preparation and photosensitizing properties of hematoporphyrin ethers. Free Radic Res Commun. 1989;7:139–142
  10. Evensen JF, Sommer S, Rimington C, Moan J. Photodynamic therapy of C3H mouse mammary carcinoma with haematoporphyrin di-ethers as sensitizers. Br J Cancer. 1987;55:483–486
  11. Moan J, Rimington C, Sommer S. Cellular uptake and photosensitizing properties of hematoporphyrin di-ethers with similar chromatographic properties as the tumorlocalizing fraction of hematoporphyrin derivative. Cancer Lett. 1987;34:283–289
  12. Moan J, Peng Q, Evensen JF, Berg K, Western A, Rimington C. Photosensitizing efficiencies, tumor- and cellular uptake of different photosensitizing drugs relevant for photodynamic therapy of cancer. Photochem Photobiol. 1987;46:713–721
  13. Sommer S, Rimington C, Moan J. Porphyrin derivatives having physical and chemical characteristics similar to those of the active components of hematoporphyrin derivative and with very strong photosensitizing effects. J Photochem Photobiol B. 1987;1:241–246
  14. Moan J, Rimington C, Western A. Hematoporphyrin ethers. III. Cellular uptake and photosensitizing properties. Int J Biochem. 1988;20:1401–1404
  15. Evensen JF, Moan J, Winkelman JW. Toxic and phototoxic effects of tetraphenylporphinesulphonate and haematoporphyrin derivative in vitro. Int J Radiat Biol Relat Stud Phys Chem Med. 1987;51:477–491
  16. Peng Q, Evensen JF, Rimington C, Moan J. A comparison of different photosensitizing dyes with respect to uptake C3H-tumors and tissues of mice. Cancer Lett. 1987;36:1–10
  17. Kongshaug M, Moan J, Brown SB. The distribution of porphyrins with different tumour localising ability among human plasma proteins. Br J Cancer. 1989;59:184–188
  18. Berg K, Western A, Bommer JC, Moan J. Intracellular localization of sulfonated meso-tetraphenylporphines in a human carcinoma cell line. Photochem Photobiol. 1990;52:481–487
  19. Berg K, Bommer JC, Winkelman JW, Moan J. Cellular uptake and relative efficiency in cell inactivation by photoactivated sulfonated meso-tetraphenylporphines. Photochem Photobiol. 1990;52:775–781
  20. Berg K, Moan J, Bommer JC, Winkelman JW. Cellular inhibition of microtubule assembly by photoactivated sulphonated meso-tetraphenylporphines. Int J Radiat Biol. 1990;58:475–487
  21. Peng Q, Moan J, Farrants G, Danielsen HE, Rimington C. Localization of potent photosensitizers in human tumor LOX by means of laser scanning microscopy. Cancer Lett. 1990;53:129–139
  22. Berg K, Madslien K, Bommer JC, Oftebro R, Winkelman JW, Moan J. Light induced relocalization of sulfonated meso-tetraphenylporphines in NHIK 3025 cells and effects of dose fractionation. Photochem Photobiol. 1991;53:203–210
  23. Berg K, Madslien K, Moan J. Retention and phototoxicity of tetra(4-sulfonatophenyl)porphine in cultivated human cells. The effect of fractionation of light. Photochem Photobiol. 1992;56:177–183
  24. Berg K, Moan J. Mitotic inhibition by phenylporphines and tetrasulfonated aluminium phthalocyanine in combination with light. Photochem Photobiol. 1992;56:333–339
  25. Berg K, Steen HB, Winkelman JW, Moan J. Synergistic effects of photoactivated tetra(4-sulfonatophenyl)porphine and nocodazole on microtubule assembly, accumulation of cells in mitosis and cell survival. J Photochem Photobiol B. 1992;13:59–70
  26. Berg K, Prydz K, Moan J. Photochemical treatment with the lysosomally localized dye tetra(4-sulfonatophenyl)porphine results in lysosomal release of the dye but not of beta-N-acetyl-d-glucosaminidase activity. Biochim Biophys Acta. 1993;1158:300–306
  27. Noodt BB, Kvam E, Steen HB, Moan J. Primary DNA damage, HPRT mutation and cell inactivation photoinduced with various sensitizers in V79 cells. Photochem Photobiol. 1993;58:541–547
  28. Berg K, Moan J. Lysosomes as photochemical targets. Int J Cancer. 1994;59:814–822
  29. Kvam E, Stokke T. Sites of photodynamically induced DNA repair in human cells. Photochem Photobiol. 1994;59:437–440
  30. Noodt BB, Moan J, Kvam E, Steen HB. No correlation between DNA strand breaks and HPRT mutation induced by photochemical treatment in V79 cells. Mutat Res. 1994;323:75–79
  31. Moan J, Ma LW, Peng Q. Photodegradation of sensitizers in mouse skin during PCT. Proc SPIE. 1996;2625:187–193
  32. Peng Q, Moan J, Nesland JM. Correlation of subcellular and intratumoral photosensitizer localization with ultrastructural features after photodynamic therapy. Ultrastruct Pathol. 1996;20:109–129
  33. Cunderlikova B, Bjorklund EG, Pettersen EO, Moan J. pH-dependent spectral properties of HpIX, TPPS2a, mTHPP and mTHPC. Photochem Photobiol. 2001;74:246–252
  34. Berg K, Bommer JC, Moan J. Evaluation of sulfonated aluminum phthalocyanines for use in photochemotherapy. A study on the relative efficiencies of photoinactivation. Photochem Photobiol. 1989;49:587–594
  35. Peng Q, Moan J, Nesland JM, Rimington C. Aluminum phthalocyanines with asymmetrical lower sulfonation and with symmetrical higher sulfonation: a comparison of localizing and photosensitizing mechanism in human tumor LOX xenografts. Int J Cancer. 1990;46:719–726
  36. Peng Q, Farrants GW, Madslien K, et al. Subcellular localization, redistribution and photobleaching of sulfonated aluminum phthalocyanines in a human melanoma cell line. Int J Cancer. 1991;49:290–295
  37. Moan J, Berg K, Bommer JC, Western A. Action spectra of phthalocyanines with respect to photosensitization of cells. Photochem Photobiol. 1992;56:171–175
  38. Moan J, Berg K, Anholt H, Madslien K. Sulfonated aluminium phthalocyanines as sensitizers for photochemotherapy. Effects of small light doses on localization, dye fluorescence and photosensitivity in V79 cells. Int J Cancer. 1994;58:865–870
  39. Peng Q, Moan J. Correlation of distribution of sulphonated aluminium phthalocyanines with their photodynamic effect in tumour and skin of mice bearing CaD2 mammary carcinoma. Br J Cancer. 1995;72:565–574
  40. Peng Q, Nesland JM, Madslien K, Danielsen HE, Moan J. Subcellular action sites of sulfonated aluminium phthalocyanines in a human cell line. Proc SPIE. 1996;2628:102–113
  41. Moan J, Iani V, Ma LW. In vivo fluorescence of phthalocyanines during light exposure. J Photochem Photobiol B. 1998;42:100–103
  42. Ma L, Moan J, Berg K. Evaluation of a new photosensitizer, meso-tetra-hydroxyphenyl-chlorin, for use in photodynamic therapy: a comparison of its photobiological properties with those of two other photosensitizers. Int J Cancer. 1994;57:883–888
  43. Peng Q, Moan J, Ma LW, Nesland JM. Uptake, localization, and photodynamic effect of meso-tetra(hydroxyphenyl)porphine and its corresponding chlorin in normal and tumor tissues of mice bearing mammary carcinoma. Cancer Res. 1995;55:2620–2626
  44. Ma LW, Moan J, Grahn MF, Iani V. A comparison of meso-tetrahydroxyphenyl-chlorin and meso-tetrahydroxyphenyl-bacteriochlorin with respect to photobleaching and PCT efficiency in vivo. Proc SPIE. 1996;2924:219–224
  45. Ma LW, Bjorklund E, Moan J. Photochemotherapy of tumours with mesotetrahydroxyphenyl chlorin is pH dependent. Cancer Lett. 1999;138:197–201
  46. Moan J, Ma LW, Bjorklund E. The effect of glucose and temperature on the in vivo efficiency of photochemotherapy with meso-tetra-hydroxyphenyl-chlorin. J Photochem Photobiol B. 1999;50:94–98
  47. Lassalle HP, Bezdetnaya L, Iani V, Juzeniene A, Guillemin F, Moan J. Photodegradation and phototransformation of 5,10,15,20-tetrakis(m-hydroxyphenyl)bacteriochlorin (m-THPBC) in solution. Photochem Photobiol Sci. 2004;3:999–1005
  48. Cunderlikova B, Moan J, Sjaastad I. pH dependent uptake of porphyrin-type photosensitizers by solid tumor cells in vitro is not induced by modification of transmembrane potential. Cancer Lett. 2005;222:39–47
  49. Cunderlikova B, Gangeskar L, Moan J. Acid-base properties of chlorin e6: relation to cellular uptake. J Photochem Photobiol B. 1999;53:81–90
  50. Friberg EG, Cunderlikova B, Pettersen EO, Moan J. pH effects on the cellular uptake of four photosensitizing drugs evaluated for use in photodynamic therapy of cancer. Cancer Lett. 2003;195:73–80
  51. Cunderlikova B, Kaalhus O, Cunderlik R, Mateasik A, Moan J, Kongshaug M. pH-dependent modification of lipophilicity of porphyrin-type photosensitizers. Photochem Photobiol. 2004;79:242–247
  52. Cunderlikova B, Sikurova L, Moan J. pH, serum proteins and ionic strength influence the uptake of merocyanine 540 by WiDr cells and its interaction with membrane structures. Bioelectrochemistry. 2003;59:1–10
  53. Uzdensky AB, Ma LW, Iani V, Hjortland GO, Steen HB, Moan J. Intracellular localisation of hypericin in human glioblastoma and carcinoma cell lines. Lasers Med Sci. 2001;16:276–283
  54. Uzdensky AB, Iani V, Ma LW, Moan J. Photobleaching of hypericin bound to human serum albumin, cultured adenocarcinoma cells and nude mice skin. Photochem Photobiol. 2002;76:320–328
  55. Uzdensky AB, Bragin DE, Kolosov MS, Kubin A, Loew HG, Moan J. Photodynamic effect of hypericin and a water-soluble derivative on isolated crayfish neuron and surrounding glial cells. J Photochem Photobiol B. 2003;72:27–33
  56. Peng Q, Brown SB, Moan J, et al. Biodistribution of a methylene blue derivative in tumor and normal tissues of rats. J Photochem Photobiol B. 1993;20:63–71
  57. Noodt BB, Rodal GH, Wainwright M, et al. Apoptosis induction by different pathways with methylene blue derivative and light from mitochondrial sites in V79 cells. Int J Cancer. 1998;75:941–948
  58. Peng Q. A preclinical and clinical study of the distribution and photodynamic effects of photosensitizers in cells and tissues. Ph.D. thesis, University of Oslo; 1994.
  59. Moan J. Properties for optimal PDT sensitizers. J Photochem Photobiol B. 1990;5:521–524
  60. Moan J, Wold E. Detection of singlet oxygen production by ESR. Nature. 1979;279:450–451
  61. Moan J, Pettersen EO, Christensen T. The mechanism of photodynamic inactivation of human cells in vitro in the presence of haematoporphyrin. Br J Cancer. 1979;39:398–407
  62. Moan J. The photochemical yield of singlet oxygen from porphyrins in different states of aggregation. Photochem Photobiol. 1984;39:445–449
  63. Moan J, Sommer S. Oxygen dependence of the photosensitizing effect of hematoporphyrin derivative in NHIK 3025 cells. Cancer Res. 1985;45:1608–1610
  64. Moan J. On the diffusion length of singlet oxygen in cells and tissues. J Photochem Photobiol B: Biol. 1990;6:343–344
  65. Moan J, Berg K. The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen. Photochem Photobiol. 1991;53:549–553
  66. Lion Y, Delmelle M, van de Vorst A. New method of detecting singlet oxygen production. Nature. 1976;263:442–443
  67. Boye E, Moan J. The photodynamic effect of hematoporphyrin on DNA. Photochem Photobiol. 1980;31:223–228
  68. Moan J, Boye E. Photodynamic effect on DNA and cell survival of human cells sensitized by hematoporphyrin. Photobiochem Photobiophys. 1981;2:301–307
  69. Juzeniene A, Juzenas P, Ma LW, Iani V, Moan J. Effectiveness of different light sources for 5-aminolevulinic acid photodynamic therapy. Lasers Med Sci. 2004;19:139–149
  70. Iani V, Moan J, Ma LW. Measurements of light penetration into human tissues in vivo. Proc SPIE. 1996;2625:378–383
  71. Moan J. Benefits and adverse effects from the combination of drugs and light. In:  Tonnessen HH editors. The photostability of drugs and drug formulations. London and Bristol: Taylor and Francis; 1996;p. 173–187
  72. Moan J, Peng Q, Sorensen R, Iani V, Nesland JM. The biophysical foundations of photodynamic therapy. Endoscopy. 1998;30:387–391
  73. Moan J, Christensen T. Photodynamic effects on human cells exposed to light in the presence of hematoporphyrin. Localization of the active dye. Cancer Lett. 1981;11:209–214
  74. Moan J, Sommer S. Action spectra for hematoporphyrin derivative and Photofrin II with respect to sensitization of human cells in vitro to photoinactivation. Photochem Photobiol. 1984;40:631–634
  75. Western A, Moan J. Action spectra for photoinactivation of cells in the presence of tetra-(3-hydroxyphenyl)porphyrin, chlorin e6 and aluminium phthalocyanine tetrasulphonate. In:  Douglas RH,  Moan J,  Dall’Aqua F editor. Light in biology and medicine. Plenum Publishing Corporation; 1988;p. 85–89
  76. Moan J, Berg K, Iani V. Action spectra of dyes relevant for photodynamic therapy. In:  Moser JG editors. Photodynamic tumor therapy. Hardwood Academic Publishers; 1998;p. 161–181
  77. Moan J, Iani V, Ma LW. Choice of the proper wavelength for photochemotherapy. Proc SPIE. 1996;2625:544–549
  78. Moan J, Johannessen JV, Christensen T, Espevik T, McGhie JB. Porphyrin-sensitized photoinactivation of human cells in vitro. Am J Pathol. 1982;109:184–192
  79. Moan J, Berg K, Kvam E, et al. Intracellular localization of photosensitizers. Ciba Found Symp. 1989;146:95–107
  80. Moan J, Western A. Fluorescence and photosensitizing effects of aluminiumphthalocyanine tetrasulfonate in cells. Trends Photochem Photobiol. 1990;1:75–79
  81. Winkelman J. Intracellular localization of “hematoporphyrin” in a transplanted tumor. J Natl Cancer Inst. 1961;27:1369–1377
  82. Berns MW, Dahlman A, Johnson FM, et al. In vitro cellular effects of hematoporphyrin derivative. Cancer Res. 1982;42:2325–2329
  83. Hisazumi H, Miyoshi N, Ueki O, Nishino A, Nakajima K. Cellular uptake of hematoporphyrin derivative in KK-47 bladder cancer cells. Urol Res. 1984;12:143–146
  84. Chan WS, Svensen R, Phillips D, Hart IR. Cell uptake, distribution and response to aluminium chloro sulphonated phthalocyanine, a potential anti-tumour photosensitizer. Br J Cancer. 1986;53:255–263
  85. Paquette B, Ali H, Langlois R, van Lier JE. Biological activities of phthalocyanines. VIII. Cellular distribution in V-79 Chinese hamster cells and phototoxicity of selectively sulfonated aluminum phthalocyanines. Photochem Photobiol. 1988;47:215–220
  86. Ji Z, Yang G, Vasovic V, et al. Subcellular localization pattern of protoporphyrin IX is an important determinant for its photodynamic efficiency of human carcinoma and normal cell lines. J Photochem Photobiol B. 2006;
  87. Noodt BB, Berg K, Stokke T, Peng Q, Nesland JM. Apoptosis and necrosis induced with light and 5-aminolaevulinic acid-derived protoporphyrin IX. Br J Cancer. 1996;74:22–29
  88. Gaullier JM, Berg K, Peng Q, et al. Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture. Cancer Res. 1997;57:1481–1486
  89. Moan J. A change in the quantum yield of photoinactivation of cells observed during photodynamic treatment. Lasers Med Sci. 1988;3:93–97
  90. Prasmickaite L, Hogset A, Berg K. Evaluation of different photosensitizers for use in photochemical gene transfection. Photochem Photobiol. 2001;73:388–395
  91. Dahle J, Bagdonas S, Kaalhus O, Olsen G, Steen HB, Moan J. The bystander effect in photodynamic inactivation of cells. Biochim Biophys Acta. 2000;1475:273–280
  92. Gaullier JM, Rodal SK, Moan J, Berg K. Combined treatment of photodynamic therapy and the topoisomerase I inhibitor camptothecin in growing V79 and NHIK 3025 cells. Proc SPIE. 1996;2924:243–251
  93. Rodal GH, Moan J, Berg K. In vitro studies of zinc(II)-phthalocyanine (Zn-PC) for use in photochemotherapy. Proc SPIE. 1997;3191:291–297
  94. Rodal GH, Rodal SK, Moan J, Berg K. Liposome-bound Zn(II)-phthalocyanine. Mechanisms for cellular uptake and photosensitization. J Photochem Photobiol B. 1998;45:150–159
  95. Moan J. Fluorescence of porphyrins in cells. In:  Andreoni A,  Cubeddu R editor. Porphyrins in tumor phototherapy. New York: Plenum Publishing Corporation; 1984;p. 109–124
  96. Moan J. Effect of bleaching of porphyrin sensitizers during photodynamic therapy. Cancer Lett. 1986;33:45–53
  97. Mang TS, Dougherty TJ, Potter WR, Boyle DG, Somer S, Moan J. Photobleaching of porphyrins used in photodynamic therapy and implications for therapy. Photochem Photobiol. 1987;45:501–506
  98. Moan J, Streckyte G, Bagdonas S, Bech O, Berg K. Photobleaching of protoporphyrin IX in cells incubated with 5-aminolevulinic acid. Int J Cancer. 1997;70:90–97
  99. Bagdonas S, Ma LW, Iani V, Rotomskis R, Juzenas P, Moan J. Phototransformations of 5-aminolevulinic acid-induced protoporphyrin IX in vitro: a spectroscopic study. Photochem Photobiol. 2000;72:186–192
  100. Ma L, Bagdonas S, Moan J. The photosensitizing effect of the photoproduct of protoporphyrin IX. J Photochem Photobiol B. 2001;60:108–113
  101. Sorensen R, Iani V, Moan J. Kinetics of photobleaching of protoporphyrin IX in the skin of nude mice exposed to different fluence rates of red light. Photochem Photobiol. 1998;68:835–840
  102. Juzenas P, Iani V, Bagdonas S, Rotomskis R, Moan J. Fluorescence spectroscopy of normal mouse skin exposed to 5-aminolaevulinic acid and red light. J Photochem Photobiol B. 2001;61:78–86
  103. Juzenas P, Sharfaei S, Moan J, Bissonnette R. Protoporphyrin IX fluorescence kinetics in UV-induced tumours and normal skin of hairless mice after topical application of 5-aminolevulinic acid methyl ester. J Photochem Photobiol B. 2002;67:11–17
  104. Moan J, Ma L, Iani V, Juzeniene A. Influence of light exposure on the kinetics of protoporphyrin IX formation in normal skin of hairless mice after application of 5-aminolevulinic acid methyl ester. J Invest Dermatol. 2005;125:1039–1044
  105. Moan J, Juzenas P, Bagdonas S. Degradation and transformation of photosensitisers during light exposure. In:  Pandalai SG editors. Recent research developments in photochemistry and photobiology. Trivandrum: Transworld Research Network; 2000;p. 121–132
  106. Moan J, Kessel D. Photoproducts formed from Photofrin II in cells. J Photochem Photobiol B. 1988;1:429–436
  107. Bonnett R, Martinez G. Photobleaching of sensitisers used in photodynamic therapy. Tetrahedron. 2001;57:9513–9547
  108. Moan J, Waksvik H, Christensen T. DNA single-strand breaks and sister chromatid exchanges induced by treatment with hematoporphyrin and light or by X-rays in human NHIK 3025 cells. Cancer Res. 1980;40:2915–2918
  109. Moan J, Pettersen EO. X-irradiation of human cells in culture in the presence of haematoporphyrin. Int J Radiat Biol Relat Stud Phys Chem Med. 1981;40:107–109
  110. Evensen JF, Moan J. Photodynamic action and chromosomal damage: a comparison of haematoporphyrin derivative (HpD) and light with X-irradiation. Br J Cancer. 1982;45:456–465
  111. Moan J, Berg K, Kvam E. Effects of photodynamic treatment on DNA and DNA-related cell functions. In:  Kessel D editors. Photodynamic therapy of neoplastic disease. Boca Raton, Ann Arbor, Boston: CRC Press; 1990;p. 197–209
  112. Kvam E, Stokke T, Moan J. The lengths of DNA fragments light-induced in the presence of a photosensitizer localized at the nuclear membrane of human cells. Biochim Biophys Acta. 1990;1049:33–37
  113. Kvam E, Moan J. A comparison of three photosensitizers with respect to efficiency of cell inactivation, fluorescence quantum yield and DNA strand breaks. Photochem Photobiol. 1990;52:769–773
  114. Moan J. Photochemotherapy of cancer. Tidsskr Nor Laegeforen. 1991;111:2962–2965
  115. Kvam E, Stokke T, Moan J, Steen HB. Plateau distributions of DNA fragment lengths produced by extended light exposure of extranuclear photosensitizers in human cells. Nucleic Acids Res. 1992;20:6687–6693
  116. Kvam E. Photosensitized DNA damage in human cells is localized in chromatin sensitive to DNAse I digestion. Int J Radiat Biol. 1994;65:405–408
  117. Kvam E, Berg K, Steen HB. Characterization of singlet oxygen-induced guanine residue damage after photochemical treatment of free nucleosides and DNA. Biochim Biophys Acta. 1994;1217:9–15
  118. Stender IM, Bech-Thomsen N, Poulsen T, Wulf HC. Photodynamic therapy with topical delta-aminolevulinic acid delays UV photocarcinogenesis in hairless mice. Photochem Photobiol. 1997;66:493–496
  119. Sharfaei S, Viau G, Lui H, Bouffard D, Bissonnette R. Systemic photodynamic therapy with aminolaevulinic acid delays the appearance of ultraviolet-induced skin tumours in mice. Br J Dermatol. 2001;144:1207–1214
  120. Sharfaei S, Juzenas P, Moan J, Bissonnette R. Weekly topical application of methyl aminolevulinate followed by light exposure delays the appearance of UV-induced skin tumours in mice. Arch Dermatol Res. 2002;294:237–242
  121. Liu Y, Viau G, Bissonnette R. Multiple large-surface photodynamic therapy sessions with topical or systemic aminolevulinic acid and blue light in UV-exposed hairless mice. J Cutan Med Surg. 2004;8:131–139

PII: S1572-1000(06)00150-5

doi: 10.1016/j.pdpdt.2006.11.002

Photodiagnosis and Photodynamic Therapy
Volume 4, Issue 1 , Pages 3-11 , March 2007

Article Tools

* Image Usage & Resolution